Venclexta – for Treatment of Previously Treated CLL With 17p Deletion, October 18th, Tacoma, WA (Non-PSONS)

Posted on 26. Aug, 2017 by in non-PSONS

DINNER INVITATION – ABBVIE ONCOLOGY
Venclexta – for Treatment of Previously Treated CLL With 17p Deletion

Date & Time: Wednesday, October 18, 2017 at 6:30 PM

Location: El Gaucho 2119 Pacific Avenue
Tacoma, Washington 98402

Presented by: Dr. Michael Choi, MD at UCSD Moores Cancer Center

Dr. Choi completed his residency and fellowship at UC San Diego School of Medicine. He is board certified in internal medicine, hematology, and medical oncology. Dr. Choi has received a young
investigator award from the tower Cancer research foundation and research training through the American society of Hematology clinical research training institute. Dr. Choi has published his research in many peer-reviewed journals including oncology, Best Practice & Research: Clinical Haematology, and molecular cancer therapeutics. Dr. Choi’s clinical interests are in the treatment of blood cancers with an emphasis on chronic lymphocytic leukemia. His research interests include highly targeted therapies that can that can be used to provide personalized and molecularly-driven treatment to patients.

Please RSVP by October 15, 2017
Cathy Simpson (425) 922- 2767
catherine.simpson@abbvie.com
abbvie.meintl.com/OHD04-OB03- 17

We look forward to seeing you there!

Comments are closed.